Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity | GenomeWeb

NEW YORK (GenomeWeb) — Though the reported specificity of sequencing-based non invasive prenatal screening tests is generally more than 99 percent, this doesn't mean that false positive rates will be below one percent for all the disorders these tests now target. In fact, depending on the abnormality in question and the gestational age of a fetus, false positive rates could be as much as 50 percent or more, according to recently published research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.